Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences.
- DOI
- 10.1016/j.omtm.2021.12.006
- Published
- 2022 Mar 10
- Container
- Molecular therapy. Methods & clinical development
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtm.2021.12.006,
title = {Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences.},
author = {Trivedi PD and Yu C and Chaudhuri P and Johnson EJ and Caton T and Adamson L and Byrne BJ and Paulk NK and Clément N},
year = {2022},
journal = {Molecular therapy. Methods \& clinical development},
doi = {10.1016/j.omtm.2021.12.006},
url = {https://doi.org/10.1016/j.omtm.2021.12.006}
}RIS
TY - JOUR TI - Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences. AU - Trivedi PD AU - Yu C AU - Chaudhuri P AU - Johnson EJ AU - Caton T AU - Adamson L AU - Byrne BJ AU - Paulk NK AU - Clément N PY - 2022 JO - Molecular therapy. Methods & clinical development DO - 10.1016/j.omtm.2021.12.006 UR - https://doi.org/10.1016/j.omtm.2021.12.006 ER -
APA
PD, T., C, Y., P, C., EJ, J., T, C., L, A., BJ, B., NK, P., & N, C. (2022). Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2021.12.006
Source records
- pubmed · retrieved 2026-09-26T04:14:53.342Z